SCHEMBL4339650

SCHEMBL4339650

CC(C)OC(Cc1cccc2c1ccn2CCOC(=O)Nc1ccc(Cl)cc1Cl)C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
HTT P42858 2/20 0.40
LMNA P02545 1/20 0.40
PPARG P37231 3/20 0.38
PPARD Q03181 3/20 0.38
PPARA Q07869 3/20 0.38
GAA P10253 2/20 0.37
POLB P06746 1/20 0.37
CHRM3 P20309 2/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
USP2 O75604 1/20 0.35
HPGD P15428 1/20 0.35
MEN1 O00255 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4338086 0.88 MEN1 (0.48) MAPTSMN1; SMN2HTTLMNAPPARG
SCHEMBL4329377 0.88 PPARG (0.39) MAPTSMN1; SMN2HTTLMNAPPARG
SCHEMBL4341327 0.85 ALOX15 (0.38) MAPTSMN1; SMN2PPARGPPARDPPARA
SCHEMBL4341303 0.80 KMT2A (0.43) MAPTSMN1; SMN2LMNAPPARGPPARD
SCHEMBL4343631 0.79 MAPT (0.44) MAPTSMN1; SMN2LMNAPPARGPPARD
SCHEMBL4340671 0.79 OPRK1 (0.44) MAPTSMN1; SMN2HTTLMNAPPARG
SCHEMBL4341814 0.78 MAPT (0.48) MAPTSMN1; SMN2HTTLMNAPOLB
SCHEMBL4333072 0.77 MCL1 (0.41) MAPTSMN1; SMN2LMNAGAAPOLB
SCHEMBL4345770 0.76 MAPT (0.47) MAPTSMN1; SMN2HTTLMNAPPARG
SCHEMBL4335326 0.75 OPRK1 (0.48) MAPTSMN1; SMN2HTTLMNAPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-20040102634-A1 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-05-27 US disclosed
EP-1380562-A1 CARBOXYLIC ACID DERIVATIVE AND SALT THEREOF Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102634-A1 Carboxylic acid derivative and salt thereof GPR119, IRS1, SLC5A1 MAPT 4654/4885SMN1; SMN2 3054/4885HTT 3749/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.